iCardio.ai

iCardio.ai is a Los Angeles-based company founded in 2019 that specializes in artificial intelligence solutions for interpreting echocardiograms. The company focuses on automating ultrasound analysis through machine learning and deep learning algorithms, aiming to improve the efficiency and accuracy of echocardiographic diagnostics in healthcare.The company offers a range of AI tools, including EchoCheck for image quality control, Quantitative for automated heart measurements, and Qualitative for detecting structural heart disease from ultrasound images. Additionally, EchoGPT generates text descriptions of ultrasound images to aid in report creation. iCardio.ai also provides custom automated solutions and datasets for clinical validation, allowing clients to tailor applications to their specific needs.iCardio.ai has partnered with major companies like Abbott to enhance imaging devices and has received FDA 510(k) clearance for its software, enabling it to offer comprehensive imaging workflows in the U.S. market. The company is currently in the seed stage and has raised $270,000 in funding.